Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Blood Cancer 2020

About Conference


Cancer conferences is rejoiced to announce the commencement of “16th International Conference on Blood Cancer” during September 14-15, 2020, in Vienna, Austria The theme of the conference will be “Novel Research Techniques in Blood Cancer Treatment”. 

Blood Cancer 2020 aims to bring together scientists, doctors, professors, lecturers in Oncology, researchers, students, training institutes, Laboratories, association and societies, and individuals have an interest in the field of Oncology & cancer.

Company organizes the conferences over 1600 Global Events inclusive of 1200+ Conferences, 600+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000+ scientific societies and publishes over 800 Open access Journals which contains over 50000 eminent personalities, reputed scientists as members of editorial board.

Why to Attend???

Blood Cancer Conference provides a global platform for exchanging ideas and makes us updated about the advancements and innovations in Oncology & cancer in a wide range. The conference regular sessions will be followed by the exhibition and sessions of Networking. Expecting leads and global business exposure from Directors, CEOs, and eminent experts from Academia and Industry.

We hope this lays an excellent platform to share your best Oncology & cancer practice initiative, research project, or provide continuing education as it relates current topics and advances around the industries and field of research. Blood Cancer 2020 provides participants with breakout sessions highlighting clinical projects, education, and research studies. The conference on Oncology & cancer has engaging interactive presentations, and keynote panel discussions with key policymakers and experts in Oncology & cancer

For more details please mail us at     

bloodcancer@europemeet.net                                                              

 

 

Sessions & Tracks

  1. Cancer Cell Biology & Genetics

Cancer may be a group of diseases involving abnormal growth of the cells with the potential to invade or unfold to numerous elements of the body. These contrast with benign   , that do not spread. Cancer cells are cells that divide unrelentingly, forming solid tumors or flooding the blood with abnormal cells. Cell division may be a traditional method utilized by the body for growth and repair. A parent cell divides to form two daughter cells, and these daughter cells are used to build new tissue or to replace cells that have died because of aging or damage. Healthy cells stop dividing once there's no longer a desire for additional daughter cells, but cancer cells continue to produce copies. They are also able to spread from one part of the body to a different in a method called metastasis. Cancer disease caused by genetic changes leading to uncontrolled cell growth and tumor formation. The basic reason for sporadic cancers is DNA damage and genomic instability. A minority of cancers are due to inherited genetic mutations. Most cancers are related to environmental, lifestyle, or activity exposures. Cancer is generally not contagious in humans, though it can be caused by oncoviruses and cancer bacteria.

  1. Various Blood Cancers & their Management

There are mainly three types of blood cancers. Leukemia is one type of cancer it is found in bone marrow and blood. It is affected by the quick production of abnormal white blood cells. These abnormal white blood cells are not able to fight infection and damage the capability of the bone marrow to produce red blood cells and platelets. Lymphoma will be directly attack the immune system, these are called lymphocytes. Lymphoma cells are in the lymph nodes, spleen, thymus, bone marrow, and other parts of the body. Myeloma is malignancy of the plasma cells. Plasma cells are white platelets that deliver sickness and disease battling antibodies in your body. Myeloma cells have the standard generation of antibodies, leaving your body's safe framework debilitated and defenseless to malady.

  1. Blood Cancer Diagnosis & Treatment

To confirm the presence of cancer and the severity or the stages of the cancer numerous cancer detection tests are carried out; certain cancer blood tests or alternative laboratory tests, such as an analysis of your urine or a biopsy of a suspicious area, to help guide the diagnosis .The other kind of tests performed to diagnose or confirm blood cancer can also include complete blood count and Blood protein testing, Tumour marker tests and Biopsy, Cytogenetic, Imaging and Radiation Oncology, Endoscopy. There are so many different types of cancer treatments are there with different possible benefits, risks and side effects. Slow-growing blood cancers can be survived by taking daily medication, whereas people with faster-growing acute blood cancers may need stronger (intensive) treatments. A stem cell transplant infuses healthy blood-forming stem cells into the body. Chemotherapy is also one of the anticancer drugs designed to interfere with and halt the growth of cancer cells in the body. Cancer cells are destroyed and relieve pain or discomfort by Radiation therapy.It may even be given before a stem cell transplant.

Types of treatments:

  1. Blood oncology and Blood Disorders

Anaemia is the most common type of blood disorder. Patients with anemia have a deficiency of oxygen-rich red blood cells or their red blood cells do not function properly. Anaemia frequently remains undiagnosed because it is an underlying condition of other health issues, including cancer, cardiovascular disease, diabetes, HIV/AIDS, inflammatory bowel disease, chronic kidney disease, and rheumatoid arthritis. Haemophilia is a rare, typically inherited blood disorder in which the blood does not properly clot and causes excessive bleeding, which can cause damage to organs, joints, and tissues. The patient may suffer excessive bleeding from the site of an injury or from internal bleeding. Clotting Disorders, Haematologists also treat conditions related to the proteins that trigger bleeding and clotting, including thrombosis and haemostasis. Thrombosis refers to the formation of abnormal blood clots that blocks blood circulation. Blood Cancers Cancerous blood conditions include leukaemia, Hodgkin lymphoma, non-Hodgkin lymphoma, and multiple myeloma. Chemotherapy is the primary treatment for blood cancer, though some patients receive radiation therapy as well and/or a transplant of stem cells or bone marrow. Antioxidants like lymphotoxin can also reduce the risk of one suffering from Blood Malignancies

  1. Cancer Biomarkers

A cancer biomarker refers to a substance or process that's indicative of the presence of cancer within the body. A biomarker is also a molecule secreted by a tumor or a specific response of the body to the presence of cancer. Genetic, epigenetic, proteomic, glycomic, and imaging biomarkers are often used for cancer diagnosing, prognosis, and epidemiology. Ideally, such biomarkers can be assayed in non-invasively collected biofluids like blood or serum. A number of gene and protein based biomarkers have already been used at some point in patient care; including, AFP (Liver Cancer), BCR-ABL (Chronic Myeloid Leukemia), BRCA1 / BRCA2 (Breast/Ovarian Cancer), BRAF V600E (Melanoma/Colorectal Cancer)

Breast : ER/PR (estrogen receptor/progesteron receptor), HER-2/neu

Colorectal : EGFR , KRAS, UGT1A1

Gastric : HER-2/neu

GIST : c-KIT

  1. Cancer Clinical Trials

Clinical trials are studies in which people volunteer to take part in tests of latest medication or procedures. Doctors use clinical trials to develop new treatments for serious diseases like cancer.In this section you can learn about clinical trials in general, find tools to help you decide if a clinical trial may be right for you, and search for specific studies you may be eligible to take part in. Clinical trials can vary in size and cost, and they can involve a single research centre or multiple centres, in one country or in multiple countries. Clinical study style aims to confirm the scientific validity and reproducibility of the results.

  1. Hemato Immunology &Stem Cell Research

Blood groups are of ABO type and but at present the Rh blood grouping of 50 well defined antigens in which 5 are more important they are D,C,c,E and e and Rh factors are of Rh positive and Rh negative which refers to the D-antigen. These D-antigen helps in prevention of erythroblast fetalis lacking of Rh antigen it defined as negative and presences of Rh antigen in blood leads to positive these leads to rh incompatibility. The prevention treatment of diseases related to the blood is called as the Hematology. The hematologists conduct works on cancer to.The disorder of system resulting in hypersensitivity is named as Clinical immunology and the abnormal growth of an infection area unit called Inflammation and therefore the arise of an abnormal immune response to the body or an immune suppression are known as Auto immune disorder. The stem cell therapy is used to treat or prevent a disease or a condition mostly Bone marrow stem cell therapy is seen and recently umbilical cord therapy Stem cell transplantation strategies remains a dangerous procedure with many possible complications; it is reserved for patients with life-threatening diseases.

  1. Bone Marrow Transplantation and surgery

Bone Marrow Transplantation: A bone marrow transplant, also known as a haemopoietic stem cell transplant, replaces damaged bone marrow with healthy bone marrow stem cells.Bone marrow is a spongy tissue found within the hollow centres of some bones.It contains specialist stem cells, which produce the body's blood cells. A biopsy may be a sample of tissue taken from the body in order to look at it more closely. A doctor should recommend a biopsy when an initial test suggests that an area of tissue in the body isn't normal. Doctors may call that area of abnormal tissue a lesion, a tumour, or a mass. Topics of discussion in the scientific sessions are Bone Marrow Surgery, Stem Cell Surgery, Hematopoietic Cell Transplantations.

  1. Traditional and Alternative Medicine for Blood Cancer

Traditional, complementary and different treatment may also be known as ‘therapy’ or ‘medicine’. These treatments are sometimes called ‘holistic’ because they don’t just look at how the disease affects the body, they aim to treat the whole person – emotionally, mentally and spiritually as well as physically. Also the terms "complementary" and "alternative" are here and there used to allude to non-customary strategies for diagnosing, counteracting, or treating cancer or its symptoms overs the same techniques as complementary medicine and the expression is used when these therapies are used instead of conventional treatments. complementary/alternative therapies are uses the knowledge and practices developed by the indigenous peoples of North America over thousands of years. It includes using natural plants with healing powers further as ceremonies like smudging and sweats.Traditional medication may be used as either a complementary or alternative treatment for cancer

  1. Haematological malignancies

Hematologic malignancies are forms of cancer that begins within the cells of blood-forming tissue, like the bone marrow, or in the cells of the immune system.Examples of hematologic cancer are acute and chronic Leukemia, lymphomas, multiple myeloma and myelodysplastic syndromes. Myeloproliferative neoplasms, or MPNs, are hematologic cancers that arise from malignant hematopoietic myeloid progenitor cells in the bone marrow, such as the precursor cells of red cells, platelets and granulocytes. Included in the MPN disease spectrum are essential thrombocythemia, polycythemia Vera and myelofibrosis. This scientific session will focus on all types of common or rare blood cancers such as acute promyelocytic leukemia (APL) and chronic myelomonocytic leukemia hairy cell leukemia (HCL), large granular lymphocytic leukemia (LGL), t-cell acute lymphoblastic leukemia (T-ALL), Non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma, Multiple myeloma, Childhood Leukemia and Myelodysplastic–Myeloproliferative diseases.

  1. Drugs for Leukemia, Lymphoma and Myeloma

The information is about a portion of the more current, directed medication medicines for blood tumour that are beginning to be utilized or have been as of late affirmed for use in individuals with Blood Cancer. The list includes generic and brand names. This page likewise records basic medication mixes utilized as a part of leukemia. The individual medications in the mixes are FDA-endorsed. List of cancer medicine approved by the nourishment and drugs Administration for non-Hodgkin lymphoma. Chemotherapy is the utilization of medicines to crush or control malignancy cells. These medications can be taken by mouth or given in a vein or a muscle. They enter the circulation system and achieve all regions of the body

Leukemia Drugs:

  • Arranon (Nelarabine)
  • Asparaginase Erwinia chrysanthemi
  • Hyper-CVAD

Lymphoma Drugs:

Myeloma Drugs:

  • Melphalan
  • Vincristine (Oncovin)
  • Cyclophosphamide (Cytoxan)
  1. Advanced Therapies in Blood Cancer

The most important cancer cure technologies are combined with natural therapies to help patent fight the disease and maintain patent quality of life. Cancer also tested by chemotherapy, radiation therapy, surgery, hormonal therapy, immunotherapy and synthetic lethality. This therapy is depends upon the grade and place of the tumor and also, the stage of the disease, as well as the general state of the patient. The removal of cancer without harm to the rest of body is the ideal goal of treatment and is usually the goal in practice.

Types of therapies:

  1. Cancer Screening & Chemotherapy

Cancer screening aims to find cancer before symptoms appear. This may involve blood tests, urine tests, DNA tests other tests, or medical imaging. The benefits of screening in terms of cancer prevention, early detection and future treatment should be weighed against any harms. Different varieties of cancer screening procedures have completely different risks, butsensible tests share some characteristics. If a test detects cancer, then that test result should conjointly result in choices for treatment. Chemotherapy is a type of cancer treatment that uses one or more anti-cancer drugs as part of a standardized chemotherapy regimen. Chemotherapy could also be given with curative intent, or it should aim to prolong life or to reduce symptoms. Chemotherapy is one of the key classes of the medical discipline specifically devoted to pharmacotherapy for cancer,  that is named medical medicine.

  1. Neurological Cancers & Brain Tumors

Neuro-oncology is the study of brain and spinal cord neoplasms, many of that are very dangerous and life-threatening astrocytoma, glioma, glioblastoma multiforme, ependymoma, pontine brain tumour, and brain stem tumors are among the many examples of these. Among the malignant brain cancers, gliomas of the brainstem and pons, glioblastoma multiforme, and high-grade astrocytoma are among the worstA tumor occurs once abnormal cells form inside the brain.There are 2 main varieties of tumors: cancerous (malignant) tumors and benign (non-cancerous) tumors.Cancerous tumors may be divided into primary tumors, that start inside the brain, and secondary tumors, that have spread from elsewhere, called brain metastasis tumors.

  1. Cancer : Traetment and Therapy

Cancer can be treated by different processes.The choice of therapy depends upon the situation and grade of the tumour and the stage of the sickness, still as the general state of the patient.Many experimental cancer treatments are also under development.Some of the individuals with cancer can have only one treatment.But the majority have a combination of treatments, like surgery with therapy and/or radiotherapy.You also have immunotherapy, targeted therapy, or hormone therapy.

  1. Cancer Vaccines

A cancer vaccine is a vaccine, that either treats existing cancer or prevents the development of cancer. Vaccines that treat existing cancer are called therapeutic cancer vaccines.Some/many of the vaccines are "autologous", being ready from samples taken from the patient, and are specific to it patient. Some kinds of cancer, like cervical cancer and some liver cancers, are caused by viruses (oncoviruses). traditional vaccines against those viruses, like HPV immunogen and hepatitis B vaccine, prevent those kinds of cancer.

  1. DNA Damage, Mutation and Cancer

DNA repair is an assortment of processes by that a cell identifies and corrects damage to the polymer molecules that write in code its ordination. In human cells, both normal metabolic activities and environmental factors like radiation will cause DNA harm, leading to as many as one million individual molecular lesions per cell per day.Many of these lesions cause structural damage to the DNA molecule and may eliminate the cell's ability to transcribe the gene that the affected DNA encodes. As a consequence, the DNA repair method is continually active as it responds to break within the DNA structure. When traditional repair processes fail, and once cellular apoptosis doesn't occur, irreparable DNA harm might occur, as well as double-strand breaks and DNA cross-linkages. This can eventually result in malignant tumors, or cancer as per the two-hit hypothesis.

  1. Oncology Radiation, Nanotechnology

Radiation therapy or radiotherapy, usually abbreviated RT, RTx, or XRT, is therapy using radiation, generally as a part of cancer treatment to manage or kill malignant cells and normally delivered by a linear accelerator. Radiation therapy is also curative in a range of kinds of cancer if they're localized to one area of the body. It may even be used as a part of adjuvant therapy, to prevent tumour recurrence after surgery to remove a primary malignant tumor. Radiation therapy is synergistic with therapy, and has been used before, during, and once therapy in vulnerable cancers. The subspecialty of oncology concerned with radiotherapy is called radiation oncology. The traditional use of nanotechnology in cancer therapeutics has been to improve the pharmacokinetics and reduce the systemic toxicities of chemotherapies through the selective targeting and delivery of these anticancer drugs to tumor tissues. Nanoparticles have high surface area to volume ratio. This allows for several practical teams to be connected to a nanoparticle, which can seek out and bind to certain tumor cells. Additionally, the small size of nanoparticles, allows them to preferentially accumulate at tumor sites. Limitations to standard cancer therapy embrace drug resistance, lack of property, and lack of solubility

 

 

Abstract Submission Criteria & Eligibility

PRESENTATION REQUIREMENTS:

  • Presenting authors are responsible for registration, travel, and hotel costs. Note: Those with accepted abstracts will receive an acceptance mail allowing them to register for the conference.
  • Abstracts will be compiled and conference books are made available to participants at the conference.
  • Any presenter who is unable to attend should arrange for another qualified individual to present the paper/poster in question. If such a change is necessary, please notify our conference team

SUBMISSION OPTIONS:

  • Oral paper presentations will have 30-minute time slots and be clustered by theme into sessions. The keynote session will have for 45-minute time slot, workshop/ special session will have 60-minute time slot and symposium will have 60-minute time slot followed by 5-minute Q&A session.
  • Graduate & Masters students are eligible to submit their abstracts under poster and e-poster presentation category.
  • Ph.D. students are eligible to submit their abstract under special YRF (young researcher’s forum), poster and e-poster presentation category.

NOTE: YRF category includes short oral presentation especially for Ph. D. students

  • Extended abstract: Submissions should utilize the Abstract Template. Papers submitted in this category may represent original empirical research, theoretical development, reviews, or critiques.

Market Analysis

Cancer is the second leading cause of death worldwide. It’s crucial to remember that cancer is not one disease – it’s more than 200 cancer diseases involved. All different, unique diseases, which require different approaches for treatment. Treatments that work for some cancers don’t work for others and sometimes those treatments simply stop working. Only worldwide research will enhance our understanding of cancer and help us find and develop better, more effective treatments. And only a global search for answers will help us get to grips with this disease. . The conference will provide with an exceptional opportunity for the delegates from Universities and Institutes to interact with the world class Scientists and Industry Professionals working in the field of cancer (or) oncology

Blood Cancer 2020 will also explore the new ideas and concepts on global scale and the topics Cancer Biology & Genetics, Organ-Defined Cancers, Oncology: Sub-Specialities, Radiation Oncology, Surgical Oncology, Cancer & Stem Cell Therapy, Precision Cancer Medicine & Oncology, Cancer Biomarkers, Cancer Epidemiology, Cancer Prevention & Research, Cancer Therapy & Treatments, Cancer Pharmacology, Cancer Vaccines, Cancer Immunology & Immunotherapy, Oncology Nursing and Care, Complementary & Alternative Methods and Cancer, Cancer Awareness and Survival, Cancer: Lifestyle and Nutrition, Cancer: Psychological & Social Aspects

Why Vienna…?

Vienna is the national capital, largest town, and one among 9 states of Austria.Vienna is Austria's primate city, with a population of regarding 1.9 million (2.6 million at intervals the metropolitan space, nearly one third of the country's population), and its cultural, economic,and political centre.It is the 7th-largest town by population at intervals town limits within the European Union.Art and culture had a protracted tradition in Austrian capital, together with theatre, opera, classical music and fine arts.The Burgtheater is taken into account one among the most effective theatres within the communicatory world aboard its branch, the Akademietheater.The Volkstheater Wien and Theater in der Josefstadt also fancy smart reputations.There is additionally a large number of smaller theatres, in several cases dedicated to less thought kinds of the arts, like trendy, experimental plays or cabaret.Vienna is additionally home to variety of opera homes, together with the podium associate der Wien, the Staatsoper and therefore the Volksoper, the latter being dedicated to the standard national capital comic opera.Classical concerts ar performed at world-famous venues like the Wiener Musikverein, home of the Austrian capital Philharmonic Orchestra known across the globe for the annual wide broadcast "New Year'sDay Concert", as well because the Wiener Konzerthaus, home of the internationally notable Austrian capital Symphony.

Target Audience

Professors, Director’s, Research scholars, Industrial professionals, Biomedical and healthcare sectors, Oncologists, Pathologists, Haematologists, Immunologists, Clinical Researchers, Scientists, Business Entrepreneurs, Training Institutes, Cancer research Students, Cancer Research Faculty, Cancer Researchers, Gynaecologists, Obstetricians, Medical Colleges, Cancer Associations and Societies, Physicians, Healthcare Scientists and Professors, Breast Cancer Surgeons, Pathologists, Radiologists, Nurse Practitioners/Nurses, Chemotherapists, Medical Devices Manufacturing Companies, Pharmaceutical Companies, Diagnostics Companies, Business Entrepreneurs, leading pharmaceutical leaders, doctors, health care professionals, molecular diagnosticians, clinicians, researchers, Executives/Managers and Business Delegates, Universities, Industries, Investigators, Post-Doctoral Fellows, Research & Diagnostic Laboratories, Clinical Fellows, Biomedical Research organizations.

Glance at the Market

Cancer Research Centres:

A. K. Khan Healthcare Trust

Aalborg Hospital - Department of Oncology

Aarhus University Hospital - Department of Oncology

Abbotsford Cancer Centre

bramson Cancer Center

ddenbrookes Oncology Centre

Aichi Cancer Center

Albert Einstein Cancer Center

Allan Blair Cancer Centre

Alvin J. Siteman Cancer Center

Arizona Cancer Center

Atlantic Cancer Research Institute

Azienda Ospedaliera Arcispedale S. Maria Nuova

Comprehensive Cancer Center Ulm

Comprehensive Cancer Center Vienna

Fraser Valley Cancer Centre
Fred and Pamela Buffett Cancer Center
Fred Hutchinson Cancer Research Center
Fudan University Shanghai Cancer Center
Fundacion Instituto Valenciano de Oncologia (IVO)
Galway University Hospital: Cancer Services
General University Hospital in Prague
Georgetown Lombardi Comprehensive Cancer Center
Georgia Regents University - Cancer Centre
Grand River Regional Cancer Centre
Gujarat Cancer & Research Institute / Gujarat Cancer Society
Harold C. Simmons Cancer Center
Helsinki University Central Hospital
Henry Moore Institute of Oncology
Herbert Irving Comprehensive Cancer Center
Herlev Hospital - Department of Oncology
Higashi Sapporo Hospital
Holden Comprehensive Cancer Center
Hollings Cancer Center
Hospital Ceske Budejovice - Comprehensive Cancer Centre
Hospital de Clínicas "Dr. Manuel Quintela"
Huntsman Cancer Institute

 

Major Cancer Associations Worldwide:

  • American Association for Cancer Research
  • Virginia Cancer Institute
  • American Brain Tumor Association
  • American Society of Pediatric Hematology/Oncology
  • Association of Cancer Physicians
  • American Childhood Cancer Organization
  • American Society of Clinical Oncology
  • Australasian Lung Cancer Trials Group
  • International Cancer Research Partnership (ICRP)
  • American Association for Cancer Research (AACR)
  • American Society of Clinical Oncology (ASCO)
  • International Agency for Research on Cancer (IARC)
  • Cancer Society of New Zealand
  • Irish Cancer Society
  • Australian Cervical Cancer Foundation
  • Medical Centre Cologne
  • Cancer Research UK
  • Australian Prostate Cancer Research
  • Peter McCollum Cancer Centre
  • The European Cancer Organization (ECCO)
  • German Cancer Research Centre

Market Analysis Report

  • The cancer diagnostics market is expected to grow at a CAGR of 11.8% during the forecast period 2017-2023. There are several methods of diagnosing cancer today such as biopsy based, endoscopy based, imaging procedure, tumour cancer diagnostics and many more. Population affected with cancer is showing a tremendous growth during last few years, which create the requirement of advanced technology for diagnosis cancer on early stage. According to the American Cancer Society, in 2017, it is estimate that around 161,360 new cases of prostate cancer will be diagnosed and around 26,730 deaths occur owing to prostate cancer in the United States. Thus, many companies are involved in collaboration in order to provide better technology for diagnosis the cancer. In this regards, in January, 2015, Roche and Qualcomm Incorporated entered into a strategic collaboration to improve remote monitoring and management of patients with chronic disease.
    The total cost of cancer therapeutics and medicines used in supportive care– measured at the ex-manufacturer price level before the application of rebates or other price concessions – reached $107 billion in 2015, representing an increase in constant dollars of 11.5% over the prior year.
  • Annual growth in the oncology drug market is expected to be 7.5 – 10.5 % through 2020, reaching $150 billion. Wider utilization of new products—especially immunotherapies—will drive much of the growth, offset by reduced use of some existing treatments with inferior clinical outcomes.
  • about $51.2 billion in 2017 and is expected to reach $66.4 billion in 2019, registering a compound annual growth rate (CAGR) of 5.4% for the period 2014-2019. It includes current issues and trends affecting the industry, costs and factors influencing demand. The report covers biological products in development, biological products in clinical trials, and currently marketed and late-stage development biologic cancer products.

 

Past Conference Report

Blood Cancer 2019

15th World Congress on Blood Cancer has been organized during October 23-24, 2019 Prague, Czech Republic. Large numbers of Participants have been involved from various aspects.

Blood Cancer 2019   proves an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various new-fangled topics related to the field of Oncology & Cancer Research. The exceedingly lifted up meeting facilitated by Conference Series was set apart with the participation of prestigious and splendid analysts, business delegates and capable understudy groups speaking to in excess of 50 nations around the globe. The meeting has had a go at establishing each perspective identified with Blood Cancer covers all the conceivable research zones and core.

We are thankful to all our speakers for encouraging and supporting us to conduct the conference and catapulting the same to pinnacle of success.

The Organizing Committee would like to thank the moderators: Ibrahim Saleh Alharbi, King Abdulaziz Medical City, Saudi Arabia for his valuable contribution which resulted in smooth functioning of the conference.

The meeting reflected various sessions, in which discussions were held on the following major scientific tracks:

Various Blood Cancers & their Management

Diagnosis & Screening of Blood Cancer

Treatment of Blood Cancer

Clinical Trials of Blood Cancer

Advanced Therapies in Blood Cancer

Epidemiology of Blood Cancer

Blood Cancer Palliative Care & Survivors

Blood Cancer Case Reports

Biomarkers in Blood Cancer

Traditional and Alternative Medicine for Blood Cancer

Anemia and Blood Disorders

Drugs for Leukemia, Lymphoma and Myeloma

Organ Specific Cancer

Leukemia Immunology

Cancer Genomics & Metabolomics

Hemato Immunology & Stem Cell Research

Bone Marrow Transplantation and Surgery

Oncology

All of them provided their fruitful contributions in the form of highly informative presentations and made the conference a top notch one.

Conference Series llC ltd is prerogative to thank the Organizing Committee Members, Keynote speakers, Chair and Co-chairs on transcribing the plenary sessions and workshops in a diversified and variegate manner to make this conference an enviable artefact.

Blood Cancer 2019  would not have reached the pinnacle if not with the support of International, multi-professional steering committee and coordination of the Journal of Blood & Lymph,Journal of Blood Disorders & Transfusion and Journal of Hematology & Thromboembolic diseases

With the grand success of Blood Cancer 2019, we are glad to announce our next upcoming conference “16th World Congress on Blood Cancer” which is going to be held in Vienna, Austria during September 14-15, 2020.

Let us meet again @ Blood Cancer 2020


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date September 14-15, 2020

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Past Conference Report

Supported By

Journal of Blood & Lymph Journal of Blood Disorders & Transfusion Journal of Hematology & Thromboembolic diseases

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by